An analysis of antidepressant prescribing trends in England 2015-2019.

Lalji, Hasnain M; McGrogan, Anita; Bailey, Sarah J

Lalji, Hasnain M; McGrogan, Anita; Bailey, Sarah J.

Afiliación

Lalji HM; Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK.
McGrogan A; Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Bailey SJ; Department of Pharmacy and Pharmacology, University of Bath, Claverton Down, Bath BA2 7AY, UK.

J Affect Disord Rep ; 6: 100205, 2021 Dec.

Article en En | MEDLINE | ID: mdl-34957433

Palabras clave

Antidepressant; CCG, Clinical Commissioning Group; COVID-19, coronavirus disease 2019; Cardiovascular prescribing; Depression; General Practice; IMD, index of multiple deprivation; Mental health; NHS, National Health Service; NHSBSA, NHS Business Services Authority; SNRI, serotonin and noradrenaline reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Affect Disord Rep Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google